SCHEMBL14742308

SCHEMBL14742308

C=COC(=O)CCCCNC(=O)OC(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.55
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 1/20 0.49
CA1 P00915 7/20 0.47
CA2 P00918 7/20 0.47
CA12 O43570 6/20 0.47
CA9 Q16790 6/20 0.47
TPSAB1 Q15661 1/20 0.44
TPSD1 Q9BZJ3 1/20 0.44
TPSG1 Q9NRR2 1/20 0.44
CYP3A4 P08684 1/20 0.42
EPHX2 P34913 1/20 0.41
DRD2 P14416 1/20 0.39
CHRM2 P08172 2/20 0.38
CHRM4 P08173 2/20 0.38
CHRM5 P08912 2/20 0.38
CHRM1 P11229 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14742742 0.95 TDP1 (0.53) TDP1MAOAMAOBMEN1GAA
SCHEMBL14742682 0.89 TDP1 (0.47) TDP1MAOAMAOBMEN1GAA
SCHEMBL22175551 0.84 TSHR (0.55) TDP1MAOAMAOBMEN1GAA
SCHEMBL16349624 0.84 TDP1 (0.66) TDP1MAOAMAOBMEN1GAA
SCHEMBL14742530 0.82 TDP1 (0.42) TDP1MAOAMAOBMEN1GAA
SCHEMBL25942884 0.82 TDP1 (0.69) TDP1MAOAMAOBMEN1GAA
SCHEMBL15373104 0.82 TDP1 (0.64) TDP1MAOAMAOBMEN1GAA
SCHEMBL25092096 0.81 TDP1 (0.67) TDP1MAOAMAOBMEN1GAA
SCHEMBL22276612 0.81 TDP1 (0.67) TDP1MAOAMAOBMEN1GAA
SCHEMBL22276594 0.81 TDP1 (0.67) TDP1MAOAMAOBMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9474804-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Pharmaceuticals, Inc. (US) 2016-10-25 US disclosed
US-9474804-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Pharmaceuticals, Inc. (US) 2016-10-25 US disclosed
US-9474804-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Pharmaceuticals, Inc. (US) 2016-10-25 US disclosed
US-20150283256-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery Arrowhead Pharmaceuticals, Inc. 2015-10-08 US disclosed
US-20150283256-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery Arrowhead Pharmaceuticals, Inc. 2015-10-08 US disclosed
US-20150283256-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery Arrowhead Pharmaceuticals, Inc. 2015-10-08 US disclosed
US-9089611-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Madison Inc. (US) 2015-07-28 US disclosed
US-9089611-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Madison Inc. (US) 2015-07-28 US disclosed
US-9089611-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Madison Inc. (US) 2015-07-28 US disclosed
US-20150110732-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery Arrowhead Madison Inc. 2015-04-23 US disclosed
US-20150110732-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery Arrowhead Madison Inc. 2015-04-23 US disclosed
US-8932572-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Madison Inc. (US) 2015-01-13 US disclosed
US-8932572-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Madison Inc. (US) 2015-01-13 US disclosed
US-8932572-B2 Poly(vinyl ester) polymers for in vivo nucleic acid delivery Arrowhead Madison Inc. (US) 2015-01-13 US disclosed
EP-2807216-A1 POLY(VINYL ESTER) POLYMERS FOR IN VIVO NUCLEIC ACID DELIVERY Arrowhead Research Corporation (US) 2014-12-03 EP disclosed
US-20130121954-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery Arrowhead Madison Inc. (US) 2013-05-16 US disclosed
US-20130121954-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery Arrowhead Madison Inc. (US) 2013-05-16 US disclosed
US-20130121954-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery Arrowhead Madison Inc. (US) 2013-05-16 US disclosed
WO-2013032829-A1 POLY(VINYL ESTER) POLYMERS FOR IN VIVO NUCLEIC ACID DELIVERY ARROWHEAD RESEARCH CORPORATION (US) 2013-03-07 WO disclosed
WO-2013032829-A1 POLY(VINYL ESTER) POLYMERS FOR IN VIVO NUCLEIC ACID DELIVERY ARROWHEAD RESEARCH CORPORATION (US) 2013-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150283256-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery PHAX, PARG, PABPC4 TDP1 1165/4885MAOA 4752/4885MAOB 4751/4885
US-20150110732-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery PHAX, PARG, PABPC4 TDP1 1165/4885MAOA 4752/4885MAOB 4751/4885
US-20130121954-A1 Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery PHAX, PARG, PABPC4 TDP1 1165/4885MAOA 4752/4885MAOB 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.